Clinical trial Recruiting at 4 sites Phase 3 Interventional Ages 18 and up

NOA HYDRATION facial gel: see if it can improve skin smoothness

Official title: A Prospective, Multicenter, Evaluator-Blinded, Randomized, No-treatment-controlled Study to Evaluate the Safety and Effectiveness of NOA HYDRATION in the Improvement of Skin Quality Including Attributes Such as Skin Smoothness

Run by AbbVie · NCT07880756 · Data updated 2026-11-12

This study tests whether NOA HYDRATION injectable gel can improve facial skin quality and smoothness in Chinese adults.

More Skin Quality trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorAbbVie
Industry-sponsored
Locations4 sites (Beijing, Beijing Municipality and 3 other locations)
StatusRecruiting
StartedSeptember 16, 2026
Main results expectedFebruary 2028
Study endsFebruary 2028
Registry record updatedOctober 19, 2026
Trial IDNCT07880756 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults seeking improvement in facial skin quality with moderate-to-severe cheek laxity who meet the FACE-Q and ACSS criteria and have no conflicting medical conditions.

Probably not a fit

Some participants may not experience noticeable skin improvement or could experience no change in skin quality.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 3 trial compares NOA HYDRATION injections to a no-treatment control to see if the gel improves facial skin smoothness in adults. Participants are randomized with a 2:1 ratio favoring the treatment group and receive intradermal injections to the face (excluding the forehead). Approximately 150 adults across seven sites in China will be enrolled and followed to assess safety and effectiveness. Inclusion focuses on adults seeking better skin quality with moderate to severe cheek laxity and dissatisfaction with appearance, while several medical exclusions ensure safety. The study aims to provide evidence on whether this investigational device can meaningfully improve facial skin attributes related to aging.

Why it matters

Potential benefit: If successful, participants may experience improved facial skin smoothness and overall appearance.

How similar studies have gone: Previous studies of similar injectable devices in dermatology have shown potential skin quality benefits but results vary by product and patient factors.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Seeking improvement of skin quality including attributes such as skin smoothness
* Has a symmetric ACSS score of Moderate (2) or Severe (3) on both cheeks
* FACE-Q Satisfaction with Skin Questionnaire sum of raw scores \<= 39 and scores of "Very Dissatisfied" or "Somewhat Dissatisfied" on the following questions:

  * How hydrated your facial skin looks?
  * How radiant your facial skin looks?

Exclusion Criteria:

* History of anaphylaxis or allergy to lidocaine, HA products, or bacterial proteins
* Active cutaneous inflammatory or infectious processes on the treatment area
* Active autoimmune disease or uncontrolled systemic disease
* Temporary soft tissue filler injections in the treatment area within 12 months
* Semi-permanent fillers anywhere in the treatment area within 36 months

Where it's running

  • Beijing Hospital /ID# 281119
    Beijing, Beijing Municipality, China
    Recruiting
  • Peking Union Medical College Hospital (West) - Xidan Campus /ID# 280945
    Beijing, Beijing Municipality, China
    Recruiting
  • Nanjing Drum Tower Hospital /ID# 281047
    Nanjing, Jiangsu, China
    Recruiting
  • Zhejiang Provincial People's Hospital /ID# 281041
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.